The first drug formulated to treat premature ejaculation delays climax and also increases reported satisfaction, researchers said on Monday.The drug, called dapoxetine, helped men delay their orgasms significantly and doubled the numbers of men and their female partners reporting “good” sexual satisfaction, they told a conference."Premature ejaculation is a really common problem, affecting between 10 and 30 percent of all men. Here is something for the first time that we have that works,” said Dr. Jon Pryor, chairman of the Department of Urologic Surgery at the University of Minnesota, who led the study.He said the drug worked quickly and with few side-effects."It gets in rapidly. It gets out rapidly. You can take it one to three hours before intercourse,” Pryor said in a telephone interview.The drug is being co-developed by Mountain View, California-based Alza Corp. and Johnson & Johnson Pharmaceutical Services LLC. Ortho Pharmaceutical will market the drug in the United States if it receives U.S. Food and Drug Administration approval. All three companies are units of Johnson & Johnson.
